Saint Joseph University-Hôtel Dieu de France Hospital, Department of Psychiatry, Beirut, Lebanon; Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France; Department of Psychiatric Emergency and Acute Care, Lapeyronie Hospital, CHRU, 34295 Montpellier, France.
Saint Joseph University-Hôtel Dieu de France Hospital, Department of Psychiatry, Beirut, Lebanon.
Eat Behav. 2024 Apr;53:101853. doi: 10.1016/j.eatbeh.2024.101853. Epub 2024 Feb 13.
Weight suppression (WS) defines the difference between the highest weight in adulthood and the current weight. WS at lowest weight is the difference between the highest and the lowest ever weight. Weight rebound is the difference between the past lowest weight and current weight. The distinction in the capacities of WS, weight rebound, and WS at the lowest weight remains unclear regarding their efficacy in forecasting clinical endpoints. This study assessed the relationship between WS, WS at lowest weight and/or weight rebound and eating disorder (ED) clinical severity.
In this retrospective cohort study, adult participants were selected at the Outpatient Unit for multidisciplinary assessment of ED, Montpellier, France, between February 2012 and October 2014 and May 2017 and January 2020. ED clinical severity was evaluated using the Eating Disorder Examination Questionnaire (EDE-Q).
The sample included 303 patients: 204 with anorexia nervosa (AN) and 99 with bulimia nervosa (BN). The EDE-Q total score was positively correlated with WS at lowest weight in patients with AN (Spearman's rho = 0.181, p = 0.015) and with BN (Spearman's rho = 0.377; p < 0.001). It was also positively correlated with weight rebound (Spearman's rho = 0.319; p = 0.003) in patients with BN. In the multivariate analysis, EDE-Q total score was associated with WS at lowest weight only in patients with BN (β = 0.265; p = 0.03).
WS at lowest weight seems to be a good measure of ED clinical severity. More research is needed for better understanding WS at lowest weight in assessment and treatment of patients with ED.
体重抑制(WS)定义为成年时的最高体重与当前体重之间的差异。最低体重时的 WS 是最高体重和最低体重之间的差异。体重反弹是过去最低体重与当前体重之间的差异。关于它们在预测临床终点方面的有效性,WS、体重反弹和最低体重时的 WS 的能力之间的区别尚不清楚。本研究评估了 WS、最低体重时的 WS 和/或体重反弹与饮食失调(ED)临床严重程度之间的关系。
在这项回顾性队列研究中,法国蒙彼利埃多学科 ED 评估门诊单元于 2012 年 2 月至 2014 年 10 月和 2017 年 5 月至 2020 年 1 月期间选择成年参与者。使用饮食失调检查问卷(EDE-Q)评估 ED 临床严重程度。
该样本包括 303 名患者:204 名厌食症患者(AN)和 99 名贪食症患者(BN)。EDE-Q 总分与 AN 患者的最低体重时的 WS 呈正相关(Spearman's rho=0.181,p=0.015),与 BN 患者的 WS 呈正相关(Spearman's rho=0.377;p<0.001)。它与 BN 患者的体重反弹也呈正相关(Spearman's rho=0.319;p=0.003)。在多变量分析中,EDE-Q 总分仅与 BN 患者的最低体重时的 WS 相关(β=0.265;p=0.03)。
最低体重时的 WS 似乎是 ED 临床严重程度的一个很好的衡量标准。需要进一步研究以更好地理解 ED 患者评估和治疗中最低体重时的 WS。